Table 1 Doses of gemcitabine, cisplatin and tipifarnib and number of patients included per dose level

From: Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours

Dose level

Gemcitabine (mg m −2 ) days 1 and 8

Cisplatin (mg m −2 ) day 1

Tipifarnib (mg twice daily) days 1–7

n

1

750

75

100

4

2

750

75

200

11

3

1000

75

200

6

4

1000

100

200

7

5

1000

100

300

3